NEW YORK, April 8, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022 and August 2, 2024, both dates inclusive (the "Class Period"), of the important...
Hence then, the article about atnm investors have opportunity to lead actinium pharmaceuticals inc securities fraud lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ATNM Investors Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit )
Also on site :
- Katie Couric Shares Photo From Hospital Bed With Important PSA: 'Wish Me Luck'
- Meghan Trainor Opens Up About Surrogacy: 'It Wasn't Our First Choice'
- Russia-Ukraine war: List of key events, day 1,428